
- Telehealth Visits

Amanda Marinoff, MD
She | Her | HersPediatric Hematology-Oncology


Amanda Marinoff, MD
She | Her | HersPediatric Hematology-Oncology- Telehealth Visits
On this page
About me
Dr. Amanda Marinoff is a pediatric hematologist-oncologist who cares for children with cancer as well as their families. She specializes in treating advanced cancers by applying precision medicine (an individualized approach that factors in genetic and environmental information) and, when appropriate, with promising therapies under evaluation in clinical trials.
In research, Marinoff focuses on identifying biomarkers (measurable substances relevant to a disease) to improve the accuracy of prognoses and on enhancing precision medicine approaches to cancer treatment. She has a special interest in sarcomas (certain tumors that arise in bone or connective tissue). She collaborates with teams in both the lab and the clinic to bring new biomarkers, risk prediction tools and treatment strategies into clinical trials, working toward better outcomes and decreased treatment side effects for pediatric, adolescent and young adult patients with cancer.
Marinoff earned her medical degree at Harvard Medical School. She completed a residency in pediatrics at Boston Children's Hospital and a fellowship in pediatric hematology-oncology at UCSF.
Education
Board Certification
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Hematology-Oncology, UCSF School of Medicine -GME
Residency
- Boston Children's Hospital
School
- Harvard Medical School
Academic Title
- Adjunct Professor
Care Keywords
Services
- Pediatric Hematology-Oncology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
